Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Balaji Prasad Maintained (AMRX) at Buy with Increased Target to $5 on, Aug 7th, 2023


Published on 2024-10-28 05:37:51 - WOPRAI, Balaji Prasad
  Print publication without navigation


Balaji Prasad of Barclays, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Buy with Increased Target from $4 to $5 on, Aug 7th, 2023.

Balaji, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources